Frec Markets Inc’s Orchestra BioMed OBIO Stock Holding History

Frec Markets Inc’s Portfolio OBIO Stock Details OBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56.3K	Hold	13,048	–	–	0.01%	897
2026 Q1	$55.5K	Buy	+13,048	New	+$55.5K	0.01%	633

Other funds holding OBIO

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Frec Markets Inc's OBIO Position: Q2 2026 in Review

Frec Markets Inc held its Orchestra BioMed (OBIO) position steady in Q2 2026 at 13,048 shares worth $56.3K. The position accounts for 0.01% of the portfolio, ranked #897.

Frec Markets Inc first reported a position in OBIO in Q1 2026 and has held it in 2 quarters since. 77 funds tracked by Wall St. Rank hold OBIO as of Q2 2026.

Frec Markets Inc held 13,048 shares of Orchestra BioMed worth $56.3K as of Q2 2026.
Frec Markets Inc left its Orchestra BioMed share count unchanged in Q2 2026.
Orchestra BioMed made up 0.01% of Frec Markets Inc's portfolio in Q2 2026, its #897 holding.
Frec Markets Inc first reported a position in Orchestra BioMed in Q1 2026 and has held it in 2 quarters since.
77 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2026.

Based on Frec Markets Inc's 13F filing for Q2 2026, filed 13 Aug 2026.